Keyword: Johnson & Johnson

News

China Blocks GSK Finance Head From Leaving Country

18.07.2013 - Chinese authorities investigating the alleged bribery of doctors and officials by GlaxoSmithKline have stopped the drugmaker's head of finance for China, a British citizen, from...

News

European Medicines Agency Pave Way for Biosimilar Drug Breakthrough

01.07.2013 - European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid...

News

Getting The Pulse

25.06.2013 - The Lion City - The Merlion - a mythical creature with the head of a lion and the body of a fish - is regarded as the Singapore icon ("Singapura" means "lion city" in Sanskrit). As...

News

Lundbeck, Merck KGaA and Others Fined for Blocking Rival Drugs

20.06.2013 - European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of €146 million ($195 million) for blocking the supply of a cheaper anti-depressant to...

News

J&J in $1 Billion Deal to Bolster Prostate-Cancer Focus

18.06.2013 - Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired...

News

After Tech Success, Israel Seeks Life Sciences Growth

06.06.2013 - Inspired by its success in high-tech electronics and software, Israel is hoping to pull off the same trick in life sciences. The Mediterranean country already boasts the world's...

News

EU to Fine Lundbeck, Others for Blocking Generic Drugs

03.06.2013 - A European regulator will fine Denmark's Lundbeck and eight other makers of generic drugs for limiting the supply of cheaper medicines, two people with knowledge of the matter said...

News

New J&J Anti-depressant Related to "Special K" Party Drug

23.05.2013 - Johnson & Johnson said it plans to seek approvals for 11 new drugs by 2017, including a new type of treatment for patients with depression that have failed to benefit from standard...